ALTERATIONS IN LIPID-METABOLISM INDUCED BY ANTIHYPERTENSIVE THERAPY

被引：11
作者：
AMERY, A
LIJNEN, P
机构：
来源：
DRUGS | 1988年 / 36卷
关键词：
D O I：
10.2165/00003495-198800362-00002
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1 / 5
页数：5
相关论文
共 13 条
[1]   THE EFFECTS OF ANTIHYPERTENSIVE DRUGS ON SERUM-LIPIDS AND LIPOPROTEINS .1. DIURETICS [J].
AMES, RP .
DRUGS, 1986, 32 (03) :260-278
[2]   THE EFFECTS OF ANTIHYPERTENSIVE DRUGS ON SERUM-LIPIDS AND LIPOPROTEINS .2. NON-DIURETIC DRUGS [J].
AMES, RP .
DRUGS, 1986, 32 (04) :335-357
[3]   THE ANTIHYPERTENSIVE EFFECTS OF DOXAZOSIN - A CLINICAL OVERVIEW [J].
COX, DA ;
LEADER, JP ;
MILSON, JA ;
SINGLETON, W .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 21 :S83-S90
[4]   EFFECT OF TERAZOSIN ON SERUM-LIPIDS [J].
DEGER, G .
AMERICAN JOURNAL OF MEDICINE, 1986, 80 (5B) :82-85
[5]   A LONG-TERM DOUBLE-BLIND COMPARISON OF DOXAZOSIN AND ATENOLOL IN PATIENTS WITH MILD TO MODERATE ESSENTIAL-HYPERTENSION [J].
FRICK, MH ;
HALTTUNEN, P ;
HIMANEN, P ;
HUTTUNEN, M ;
PORSTI, P ;
PITKAJARVI, T ;
POYHONEN, L ;
PYYKONEN, ML ;
REINIKAINEN, P ;
SALMELA, P ;
SARASTE, M .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 21 :S55-S62
[6]   ANTIHYPERTENSIVE TREATMENT AND PLASMA-LIPOPROTEIN LEVELS - THE ASSOCIATIONS IN DATA FROM A POPULATION STUDY [J].
MACMAHON, SW ;
MACDONALD, GJ .
AMERICAN JOURNAL OF MEDICINE, 1986, 80 (2A) :40-47
[7]   EFFECTS OF INDORAMIN AND METOPROLOL ON PLASMA-LIPIDS AND LIPOPROTEINS [J].
MARTINEZ, TLR ;
AURIEMO, CRC ;
MACHADO, AMO ;
CUNHA, MA ;
FERES, MC ;
MALDJIAN, S ;
WORTSMAN, A ;
DELBONI, FOH .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1986, 8 :S76-S79
[8]  
MCKENNEY JM, 1986, PHARMACOTHERAPY, V6, P179
[9]   SERUM-LIPOPROTEINS DURING ANTIHYPERTENSIVE THERAPY WITH BETA-BLOCKERS AND DIURETICS - A CONTROLLED LONG-TERM COMPARATIVE TRIAL [J].
MIDDEKE, M ;
WEISWEILER, P ;
SCHWANDT, P ;
HOLZGREVE, H .
CLINICAL CARDIOLOGY, 1987, 10 (02) :94-98
[10]   COMPARISON OF THE EFFECT OF INDORAMIN AND PRAZOSIN ON BLOOD-PRESSURE AND LIPID PROFILES IN ESSENTIAL-HYPERTENSION [J].
OVERLACK, A ;
STUMPE, KO .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1986, 8 :S53-S55
12